Genmab
GMAB
GMAB
180 hedge funds and large institutions have $1.15B invested in Genmab in 2022 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 57 increasing their positions, 82 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
12% less funds holding
Funds holding: 204 → 180 (-24)
30% less repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 82
54% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 37
Holders
180
Holding in Top 10
2
Calls
$4.41M
Puts
$32K
Top Buyers
| 1 | +$23.7M | |
| 2 | +$20.2M | |
| 3 | +$13.8M | |
| 4 |
American Century Companies
Kansas City,
Missouri
|
+$5.92M |
| 5 |
F
Folketrygdfondet
Oslo Norway,
Norway
|
+$4.94M |
Top Sellers
| 1 | -$40.2M | |
| 2 | -$31.9M | |
| 3 | -$24.8M | |
| 4 |
Goldman Sachs
New York
|
-$14.8M |
| 5 |
Stifel Financial
St. Louis,
Missouri
|
-$14.2M |